International Stem Cell (ISCO) Market Capitalization (2010 - 2026)

International Stem Cell (ISCO) has reported Market Capitalization for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 18.75% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 18.75% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 75.0% from the prior year.
• Market Capitalization was $1.5 million for Q2 2026 at International Stem Cell, up from $1.1 million in the prior quarter.
• Over five years, Market Capitalization peaked at $3.8 million in Q1 2022 and troughed at $480263.3 in Q4 2023.
• A 5-year average of $1.4 million and a median of $1.0 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 68.29% in 2023 and soared 166.67% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $1.4 million in 2022, then slumped by 66.67% to $480263.3 in 2023, then surged by 33.33% to $640351.1 in 2024, then surged by 75.0% to $1.1 million in 2025, then surged by 35.71% to $1.5 million in 2026.
• The last three Market Capitalization figures came in at $1.5 million (Q2 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.